Russell Investments Group, Ltd. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$19,047,000
+74.2%
110,683
+27.0%
0.03%
+77.8%
Q2 2021$10,936,000
+28678.9%
87,160
+30698.6%
0.02%
Q1 2021$38,000
-98.1%
283
-98.7%
0.00%
-100.0%
Q2 2020$2,021,000
-35.5%
21,223
-39.1%
0.01%
-37.5%
Q1 2020$3,131,000
+18.3%
34,866
-30.1%
0.01%
+60.0%
Q4 2019$2,646,000
+39.9%
49,915
+4.3%
0.01%
+25.0%
Q3 2019$1,891,000
+80.4%
47,839
+87.6%
0.00%
+100.0%
Q2 2019$1,048,000
-11.6%
25,5060.0%0.00%0.0%
Q1 2019$1,186,000
+38.6%
25,506
+29.9%
0.00%0.0%
Q4 2018$856,000
+113.5%
19,637
+179.8%
0.00%
+100.0%
Q3 2018$401,000
+88.3%
7,017
+50.5%
0.00%
Q2 2018$213,000
-15.8%
4,663
-27.9%
0.00%
Q1 2018$253,000
+5.9%
6,463
+17.1%
0.00%
Q4 2017$239,000
-86.3%
5,519
-88.2%
0.00%
-100.0%
Q3 2017$1,742,000
+187.9%
46,684
+134.5%
0.00%
+200.0%
Q2 2017$605,000
-17.9%
19,911
-28.5%
0.00%0.0%
Q1 2017$737,000
+95.0%
27,850
+88.9%
0.00%0.0%
Q4 2016$378,00014,7420.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders